Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL1938210 Target Snapshot

Lysine-specific demethylase 2A · SINGLE PROTEIN · Homo sapiens

157Compounds
48Assays
1Approved Drugs
202.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9Y2K7. Use UniProt Q9Y2K7 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9Y2K7 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Lysine-specific demethylase 2A as ChEMBL target CHEMBL1938210, mapped to UniProt Q9Y2K7. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Lysine-specific demethylase 2A
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL1938210
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9Y2K7
Lysine-specific demethylase 2A
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Lysine-specific demethylase 2A is the right protein anchor across sources, using UniProt Q9Y2K7 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelLysine-specific demethylase 2A
UniProt AccessionQ9Y2K7
Component TypeProtein
Sequence Length1162 aa

Lysine-specific demethylase 2A

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Lysine-specific demethylase 2A, mapped to UniProt Q9Y2K7. Sequence length is 1162 aa.

Mapped IDQ9Y2K7
Review nameLysine-specific demethylase 2A
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

1
Approved
Assay Mix

Activity Type Distribution

IC50181.0
KI11.0
EC506.0
KD4.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL2392184 8.09 Kd 8.2 Preclinical
CHEMBL2392184 7.95 Ki 11.3 Preclinical
CHEMBL3621881 7.2 IC50 63.1 Preclinical
CHEMBL5173876 7.2 IC50 63.0 Preclinical
CHEMBL4283409 7.0 IC50 100.0 Preclinical
CHEMBL4288093 7.0 IC50 100.0 Preclinical
CHEMBL4294926 7.0 IC50 100.0 Preclinical
CHEMBL3621878 6.9 IC50 125.89 Preclinical
CHEMBL2392184 6.87 IC50 135.0 Preclinical
CHEMBL5723343 6.8 IC50 160.0 Preclinical
Distribution

pChEMBL Value Distribution

40
5.0
17
5.5
16
6.0
13
6.5
5
7.0
3
7.5
2
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

48
Total Assays
120
Tested Compounds
2
Assay Types
Binding — 47 assays, 120 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 19 16 5.8
single protein format 17 75 5.3
cell-based format 11 29 5.3
Functional — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 1 6.8

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine